SLU-PP-332 Caps (500mcg)

For Research Use Only — Not for Human Use

Intended for laboratory research use only (e.g., analytical and in-vitro studies). Not for human use.

SLU-PP-332 is a synthetic small-molecule research compound studied for its role in metabolic regulation and nuclear receptor signaling pathways. This capsule format delivers SLU-PP-332 in a stabilized encapsulated format for laboratory research use.

SLU-PP-332 is examined in laboratory settings for its connection to estrogen-related receptor (ERR) activation, which influences cellular energy metabolism and mitochondrial function.

GENIQ supplies SLU-PP-332 Caps strictly for laboratory research only—not for human or animal use.

$149.99

Categories: ,
  • Official retailer
  • Quality guaranteed
  • Free delivery from $99
  • Free returns is available

What Is SLU-PP-332 Caps?

SLU-PP-332 is a synthetic small-molecule research compound studied for its role in metabolic regulation and nuclear receptor signaling pathways. This capsule format delivers SLU-PP-332 in a stabilized encapsulated format for laboratory research use.SLU-PP-332 is examined in laboratory settings for its connection to estrogen-related receptor (ERR) activation, which influences cellular energy metabolism and mitochondrial function.GENIQ supplies SLU-PP-332 Caps strictly for laboratory research only—not for human or animal use.

Peptide Overview

SLU-PP-332 is frequently studied in research focused on mitochondrial biology, fatty-acid oxidation, and skeletal muscle metabolism. In controlled laboratory environments, researchers examine how SLU-PP-332 Caps may promote changes in:

Estrogen-related receptor (ERR) activation
Mitochondrial biogenesis signaling
Fatty-acid oxidation pathways
Skeletal muscle metabolic gene expression
Endurance-related signaling markers
Cellular energy utilization models
Exercise-mimetic research models

All findings remain limited to preclinical and in-vitro experimental environments.

History of SLU-PP-332

SLU-PP-332 was developed by researchers at Saint Louis University as part of a program designing synthetic agonists for the estrogen-related receptors (ERRα, ERRβ, ERRγ). Scientists identified that activating these nuclear receptors could reproduce many of the cellular adaptations associated with aerobic exercise. Because of this interaction, SLU-PP-332 became a compound of interest in studies involving:

Exercise-mimetic signaling research
Nuclear receptor pharmacology
Mitochondrial function studies
Metabolic syndrome research models
Skeletal muscle fiber-type studies
Endurance capacity research

Peptide Structure

Chemical Name: SLU-PP-332 Classification: Synthetic ERRα/β/γ agonist (small molecule) Form Supplied: Oral capsule, 500mcg per capsule (100 capsules per bottle)

Certificates of Analysis

Every batch of GENIQ SLU-PP-332 Caps is verified by third-party laboratory testing confirming identity, purity, and capsule content accuracy. Certificates of Analysis (COA) are available upon request for research verification.

Research Findings

Research involving SLU-PP-332 commonly focuses on:

ERR receptor activation: Studies evaluate how synthetic agonism of ERRα/β/γ affects gene transcription.
Mitochondrial biogenesis: Researchers investigate increases in mitochondrial density in skeletal muscle models.
Fatty-acid oxidation: Laboratory models track lipid metabolism changes following ERR activation.
Exercise capacity markers: Experimental studies analyze endurance-related adaptations without physical training.
Gene-expression modulation: Investigations explore transcriptional activity tied to metabolic pathways.

These findings reflect laboratory experiments only and do not indicate clinical outcomes.

References

Peer-reviewed literature references are available to qualified researchers upon request.

FAQ

Are GENIQ peptides pharmaceutical products?

No. They are not drugs, supplements, or therapeutic items. All compounds are provided strictly for laboratory research.

Qualified researchers, laboratories, and institutions working within applicable laws and regulations.

Yes. Each peptide includes a Certificate of Analysis confirming identity and purity testing when available for that lot.

Only storage temperature and solvent-compatibility notes when listed on the product page. GENIQ does not provide guidance on preparation or application. Buyers follow their institution’s laboratory protocols.

No. For Research Use Only — Not for Human Use. Not for human or animal consumption.

For Research Use Only — Not for Human Use

Sold exclusively as laboratory research materials. Not for human or animal consumption, clinical use, or household use.

Intended research use: Laboratory and in-vitro research, including analytical characterization and pathway / receptor-binding studies as applicable to this compound. Not for human consumption, clinical use, or diagnostic use on humans.

SLU-PP-332 is a synthetic small-molecule research compound studied for its role in metabolic regulation and nuclear receptor signaling pathways. This capsule format delivers SLU-PP-332 in a stabilized encapsulated format for laboratory research use.

SLU-PP-332 is examined in laboratory settings for its connection to estrogen-related receptor (ERR) activation, which influences cellular energy metabolism and mitochondrial function.

GENIQ supplies SLU-PP-332 Caps strictly for laboratory research only—not for human or animal use.